Michelle J. Bound
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Inter-individual variation in gastric emptying is related to GLP-1 response to intraduodenal glucose exposure in health.
Journal: The Journal of clinical endocrinology and metabolism
Published: April 17, 2026
Effects of Pharmacological GIP Infusion on Insulin, Glucagon, and Cardiovascular Responses During Hyperglycemia in Type 2 Diabetes.
Journal: Diabetes
Published: March 16, 2026
Disparities in GLP-1 and GIP responses to small intestinal glucose infusion in individuals with well- and poorly-controlled type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: March 04, 2026
Metformin slows intestinal glucose absorption in type 2 diabetes, irrespective of the timing of its administration.
Journal: Diabetes, obesity & metabolism
Published: May 30, 2025
Impact of the timing of metformin administration on the plasma lactate response to intraduodenal glucose infusion in type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: October 31, 2024
Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes.
Journal: Diabetes, obesity & metabolism
Published: April 25, 2024
Gastric emptying during and following resolution of moderate diabetic ketoacidosis in type 1 diabetes: a case series.
Journal: BMJ open diabetes research & care
Published: October 27, 2023
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821.
Journal: Diabetes care
Published: November 10, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial.
Journal: Diabetes care
Published: January 27, 2020
The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes.
The prevalence and impact of low faecal elastase-1 in community-based patients with type 2 diabetes.
Journal: Diabetes research and clinical practice
Published: July 29, 2019
Last Updated: 09/26/2026